Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 8Genitourinary 7Breast 6Tumor-Agnostic 2Thoracic 2Lymphoid 2Other hematologic neoplasm 1Head & Neck 1Gynecologic 1Endocrine 1CNS 1

Conditions

Multiple Endocrine Neoplasia Type 1 1Diabetes Mellitus, Type 1 1

Interventions

Eating 5Standard of Care 4Radiofrequency Ablation 4Exercise 4Surgical Procedures, Operative 3Radiosurgery 3Endoscopic Mucosal Resection 3Adrenalectomy 3lutetium Lu 177 dotatate 2Yoga 2Saline Solution 2Robotic Surgical Procedures 2Resistance Training 2Proton Therapy 2Propofol 2Palliative Care 2Octreotide 2Magnetic Resonance Imaging 2Lutetium-177 2Liquid Biopsy 2Interviews as Topic 2Hydrocortisone 2Diet, Mediterranean 2Diet 2Desflurane 2Data Collection 2Conversion to Open Surgery 2Control Groups 2Calcium 23-Iodobenzylguanidine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × High-Intensity Interval Training × Endocrine × Clear all
NCT06080542 2023-10-19

TAILOR/1b

University of Valencia

Phase NA Completed
40 enrolled
Endocrine

Diabetes Mellitus, Type 1, Multiple Endocrine Neoplasia Type 1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡